AMP-activated protein kinase regulates the expression of human telomerase reverse transcriptaseopen access
- Authors
- Jo, Daum; Park, Rackhyun; Kim, Hyunju; Jang, Minsu; Lee, Eun-Ju; Jang, Ik-Soon; Park, Junsoo
- Issue Date
- Nov-2018
- Publisher
- PUBLIC LIBRARY SCIENCE
- Citation
- PLOS ONE, v.13, no.11
- Journal Title
- PLOS ONE
- Volume
- 13
- Number
- 11
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/560
- DOI
- 10.1371/journal.pone.0207864
- ISSN
- 1932-6203
- Abstract
- The expression of hTERT in tumor cells contributes to oncogenic transformation by promoting immortalization. For this reason, hTERT is one of the major targets for cancer therapy, and an efficient method to downregulate hTERT expression is required for treatment of hTERT-positive cancer. In this report, we demonstrated that inhibition of AMP-activated protein kinase (AMPK) downregulates the expression of hTERT. We screened cell signaling pathways in AMPK alpha 1 knockout cells and found that AMPK alpha 1 is required for activity of the hTERT promoter. AMPK alpha 1 knockout cells showed decreased expression of hTERT mRNA and protein. We also demonstrated that compound C, a reversible AMPK inhibitor, suppressed the expression of hTERT. However, AMPK activators, including AICAR and metformin, did not increase the level of hTERT protein. Finally, we showed that tumor cells stably expressing hTERT are resistant to compound C treatment. These results indicate that AMPK activity is required for tumor progression.
- Files in This Item
-
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/560)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.